275 related articles for article (PubMed ID: 36782276)
1. Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma.
Xiao Y; Zhou C; Ni X; Huang P; Wu F; Yang C; Zeng M
Cancer Imaging; 2023 Feb; 23(1):15. PubMed ID: 36782276
[TBL] [Abstract][Full Text] [Related]
2. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance.
Rhee H; Kim MJ; Park YN; An C
Eur Radiol; 2019 Jun; 29(6):3111-3121. PubMed ID: 30560357
[TBL] [Abstract][Full Text] [Related]
3. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Sheng R; Zhang Y; Wang H; Zhang W; Jin K; Sun W; Dai Y; Zhou J; Zeng M
Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
[TBL] [Abstract][Full Text] [Related]
4. MRI for Hepatitis B-Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study.
Sheng R; Wang H; Zhang Y; Sun W; Jin K; Dai Y; Zhang W; Zeng M; Zhou J
J Magn Reson Imaging; 2024 Mar; 59(3):1093-1104. PubMed ID: 37309823
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
[TBL] [Abstract][Full Text] [Related]
6. Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Mahmoudi S; Bernatz S; Ackermann J; Koch V; Dos Santos DP; Grünewald LD; Yel I; Martin SS; Scholtz JE; Stehle A; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
Clin Oncol (R Coll Radiol); 2023 May; 35(5):e312-e318. PubMed ID: 36804153
[TBL] [Abstract][Full Text] [Related]
7. Clinical features of sarcomatoid change in patients with intrahepatic cholangiocarcinoma and prognosis after surgical liver resection: A Propensity Score Matching analysis.
Wang T; Kong J; Yang X; Shen S; Zhang M; Wang W
J Surg Oncol; 2020 Mar; 121(3):524-537. PubMed ID: 31867746
[TBL] [Abstract][Full Text] [Related]
8. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract][Full Text] [Related]
9. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
[TBL] [Abstract][Full Text] [Related]
10. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
Shen K; Mo W; Wang X; Shi D; Qian W; Sun J; Yu R
Eur Radiol; 2023 Dec; 33(12):8986-8998. PubMed ID: 37392232
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of microvascular invasion in patients with intrahepatic mass-forming cholangiocarcinoma based on magnetic resonance images.
Chen S; Wan L; Zhao R; Peng W; Li Z; Zou S; Zhang H
Abdom Radiol (NY); 2023 Apr; 48(4):1306-1319. PubMed ID: 36872324
[TBL] [Abstract][Full Text] [Related]
12. LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study.
Hwang JA; Lee S; Lee JE; Yoon J; Choi SY; Shin J
J Magn Reson Imaging; 2023 Mar; 57(3):930-938. PubMed ID: 35833798
[TBL] [Abstract][Full Text] [Related]
13. MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma.
Ma X; Liu L; Fang J; Rao S; Lv L; Zeng M; Shi Y; Yang C
Cancer Imaging; 2020 Jun; 20(1):40. PubMed ID: 32576283
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification for overall survival and recurrence-free survival after R0 resection for solitary intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Eur J Radiol; 2023 Dec; 169():111190. PubMed ID: 37979460
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities.
Zen Y
Hum Pathol; 2023 Feb; 132():197-207. PubMed ID: 35697170
[TBL] [Abstract][Full Text] [Related]
16. Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma.
Chen X; Zhu J; Zou Z; Du M; Xie J; Ye Y; Zhang L; Li Y
Abdom Radiol (NY); 2023 Feb; 48(2):567-578. PubMed ID: 36401626
[TBL] [Abstract][Full Text] [Related]
17. Nomogram based on preoperative clinical and MRI features to estimate the microvascular invasion status and the prognosis of solitary intrahepatic mass-forming cholangiocarcinoma.
Chen S; Wan L; Zhao R; Peng W; Liu X; Li L; Zhang H
Abdom Radiol (NY); 2024 Feb; 49(2):425-436. PubMed ID: 37889266
[TBL] [Abstract][Full Text] [Related]
18. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
20. Preoperative MRI features predicting very early recurrence of intrahepatic mass-forming cholangiocarcinoma after R0 resection: a comparison with the AJCC 8th edition staging system.
Chen S; Wan L; Zhao R; Peng W; Zou S; Zhang H
Abdom Radiol (NY); 2024 Jan; 49(1):21-33. PubMed ID: 37815613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
